𝔖 Bobbio Scriptorium
✦   LIBER   ✦

78 In vitro anti-myxovirus activity of polyoxometalates: S. Shigeta,1∗ S. Mori,1 M. Hosoya,1 M. Baba,1 R.F. Schinazi,2 A.M. Khenkin,3 & C.L. Hill.3 Department of Microbiology, Fukushima Medical College, Fukushima, 960-12, Japan,1 Veterans Affairs Medical Center and Laboratory of Biochemical Pharmacology, Department of Pediatrics2 and Chemistry3, Emory University, Atlanta, GA, 30033, USA

Book ID
118393523
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
73 KB
Volume
23
Category
Article
ISSN
0166-3542

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination studies with antiviral compo
Combination studies with antiviral compounds to prevent reactivation of latent HIV-1 in OM-10.1 cells : P.M. Feorino,1,2 S.T. Butera,3 T.M. Folks,3 and R.F. Schinazi1,2 Laboratory of Biochemical Pharmacology, Dept. of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322,1 Veterans Affairs Medical Center, Decatur, GA 30033,2 and Retrovirus Diseases Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control, Atlanta, GA 30333, USA.3
📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 66 KB
Synthesis and anti-HIV and anti-HBV acti
Synthesis and anti-HIV and anti-HBV activity of enantiomerically pure oxathiolane nucleosides: C.K. Chu1, J.W. Beach1, L.S. Jeong1, A. Alves1, R.F. Schinazi2, C.-N. Chang3, S.-L. Doong3, and Y.-C. Cheng3. 1Department of Medicinal Chemistry, The University of Georgia, College of Pharmacy, Athens, GA. 30602, 2Department of Pediatrics Emory School of Medicine/VA Medical Center, Atlanta, GA. 30033 and 3Department of Pharmacology Yale School of Medicine, New Haven, CT. 06510, U.S.A.
📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 67 KB
139 MKC-442, a highly potent and specifi
139 MKC-442, a highly potent and specific inhibitor of HIV-1: M. Baba,1 S. Shigeta,1 S. Yuasa,2 M. Ubasawa,2 H. Tanaka,3 T. Miyasaka,3 R.T. Walker,4 and E. De Clercq5 Department of Microbiology, Fukushima Medical College, Fukushima 960-12,1 Mitsubishi Kasei Corporation Research Center, Yokohama 227,2 Department of Synthetic Chemistry, Showa University, Tokyo 142,3 Japan; University of Birmingham, Birmingham B15 2TT, Great Britain4; and Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium5
📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 81 KB
Development of anti-HSV screening system
Development of anti-HSV screening system using suspension cell line and screening several nucleoside analogues in this method: T. Kira1, A. Kakefuda2, H. Awano2, S. Shuto2, A. Matsuda2, M. Baba3, M. Saneyoshi4, S. Shigeta1 1Department of Microbiology, Fukushima Medical College, Fukushima 960-12, Fukushima 2 Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060, Hokkaido 3 Division of Human Retroviruses, Center for Chronic Viral Diseases, Faculty of Medicine, Kagoshima University, Kagoshima 890, Kagoshima 4 Department of Biological Sciences, The Nishi-Tokyo University, Uenohara 409-01, Yamanashi, Japan
📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 68 KB
An orally bioavailable sulfated oligosac
An orally bioavailable sulfated oligosaccharide derivative that inhibits human immunodeficiency virus in vitro and provides sustainned drug level in mammals with low-anticoagulant activity: T. Shoji1, H. Nakashima2, A. Kasai1, M. Iiyama1, N. Takahashi1, K. Inazawa2, K. Ichiyama2, M. Ito2, N. Yamamoto1 and R.F. Schinazi4 1Central Research Laboratotries, Dainippon Ink & Chemicals, Inc. 631 Sakado, Sakura-shi, Chiba, 285 Japan; 2Department of Microbiology, Yamanashi Medical University, Yamanashi, Japan; 3Department of Microbiology, School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan; 4Veterans Affairs Medical Center and Department of Pediatrics, Laboratory of Biochemical Pharmacology, Emory University School of Medicine, Decatur, Georgia, 30033, USA
📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 114 KB
78 Effect of human serum on the in vitro
78 Effect of human serum on the in vitro Anti-HIV-1 activity of hept derivatives as related to their lipophilicity and serum protein binding capacity: M. Baba,1 S. Yuasa,2 T. Niwa,2 H. Takashima,2 M. Ubasawa,2 H. Tanaka,3 T. Miyasaka,3 R.T. Walker,4 J. Balzarini,5 E. De Clercq,5 and S. Shigeta1 1Department of Microbiology, Fukushima Medical College, Fukushima 960-12, 2Mitsubishi Kasei Corporation Research Center, Yokohama 227, 3Showa University, Tokyo 142, Japan, 4University of Birmingham, Birmingham B15 2TT, United Kingdom, and 5Rega Institute, Katholieke Universiteit Leuven, B-3000, Leuven, Belgium
📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 57 KB